Needham reiterated coverage on Gamida Cell with a new price target

11/16/21 9:17:28 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Needham reiterated coverage of Gamida Cell with a rating of Buy and set a new price target of $12.00 from $14.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$GMDA

Date	Price Target	Rating	Analyst
11/16/2021	$14.00 → $12.00	Buy	Needham
11/16/2021	$17.00 → $15.00	Outperform	Oppenheimer
11/1/2021	$11.00	Buy	Alliance Global Partners